THE RAT ALPHA(1B) ADRENERGIC-RECEPTOR GENE MIDDLE PROMOTER CONTAINS MULTIPLE BINDING-SITES FOR SEQUENCE-SPECIFIC PROTEINS INCLUDING A NOVEL UBIQUITOUS TRANSCRIPTION FACTOR

被引:34
作者
GAO, B
SPECTOR, MS
KUNOS, G
机构
[1] VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, SCH MED, DEPT PHARMACOL, RICHMOND, VA 23298 USA
[2] VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, SCH MED, DEPT TOXICOL, RICHMOND, VA 23298 USA
[3] VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, SCH MED, DEPT MED, RICHMOND, VA 23298 USA
关键词
D O I
10.1074/jbc.270.10.5614
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcription of the rat alpha(1B) adrenergic receptor (alpha(1B)AR) gene in the liver is controlled by three promoters that generate three mRNAs. The middle promoter (P2), located between -432 and -813 base pairs upstream from the translation start codon and lacking a TATA box, is responsible for generating the major, 2.7-kilobase mRNA species expressed in many tissues (Gao, B., and Kunos, G. (1994) J. Biol. Chem. 269, 15762-15767). DNase I footprinting using rat liver nuclear extracts identified three protected regions in P2: footprint I (-432 to -452), footprint II(-490 to -540), and footprint III (-609 to -690). Putative response elements in footprints I and III were not analyzed except the AP2 binding site in footprint III, which could be protected by purified AP2 protein. Footprint II contains four sites corresponding to half of the NF-I consensus sequence, but DNA mobility shift assays indicate that this footprint binds two proteins distinct from NF-I: a ubiquitous CP1-related factor and another novel factor, termed alpha-Adrenergic Receptor Transcription Factor (alpha ARTF), which binds to two separate sites in this region. The alpha ARTF is widely distributed, with the highest amounts found in brain, followed by liver, kidney, lung, and spleen, but no detectable activity in heart. Deletions of alpha ARTF binding sites nearly abolished P2 promoter activity, which suggests that the alpha ARTF is essential for the transcription of the alpha(1B)AR gene in most tissues.
引用
收藏
页码:5614 / 5619
页数:6
相关论文
共 39 条
[1]   DIFFERENCES AND SIMILARITIES IN DNA-BINDING PREFERENCES OF MYOD AND E2A PROTEIN COMPLEXES REVEALED BY BINDING-SITE SELECTION [J].
BLACKWELL, TK ;
WEINTRAUB, H .
SCIENCE, 1990, 250 (4984) :1104-1110
[2]   PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PROMOTER-SPECIFIC TRANSCRIPTION FACTOR, SPL [J].
BRIGGS, MR ;
KADONAGA, JT ;
BELL, SP ;
TJIAN, R .
SCIENCE, 1986, 234 (4772) :47-52
[3]   A LIVER-SPECIFIC FACTOR ESSENTIAL FOR ALBUMIN TRANSCRIPTION DIFFERS BETWEEN DIFFERENTIATED AND DEDIFFERENTIATED RAT HEPATOMA-CELLS [J].
CEREGHINI, S ;
BLUMENFELD, M ;
YANIV, M .
GENES & DEVELOPMENT, 1988, 2 (08) :957-974
[4]   A LIVER-SPECIFIC DNA-BINDING PROTEIN RECOGNIZES MULTIPLE NUCLEOTIDE SITES IN REGULATORY REGIONS OF TRANSTHYRETIN, ALPHA-1-ANTITRYPSIN, ALBUMIN, AND SIMIAN-VIRUS 40 GENES [J].
COSTA, RH ;
GRAYSON, DR ;
XANTHOPOULOS, KG ;
DARNELL, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (11) :3840-3844
[5]   PURIFIED COFACTORS AND HISTONE H1 MEDIATE TRANSCRIPTIONAL REGULATION BY CTF NF-I [J].
DUSSERRE, Y ;
MERMOD, N .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (11) :5228-5237
[6]  
FARRANCE IKG, 1992, J BIOL CHEM, V267, P17234
[7]   ALPHA-1-ADRENOCEPTOR CLASSIFICATION - SHARPENING OCCAM RAZOR [J].
FORD, APDW ;
WILLIAMS, TJ ;
BLUE, DR ;
CLARKE, DE .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (06) :167-170
[8]   HETERODIMERS OF MYOGENIC HELIX-LOOP-HELIX REGULATORY FACTORS AND E12 BIND A COMPLEX ELEMENT GOVERNING MYOGENIC INDUCTION OF THE AVIAN CARDIAC ALPHA-ACTIN PROMOTER [J].
FRENCH, BA ;
CHOW, KL ;
OLSON, EN ;
SCHWARTZ, RJ .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (05) :2439-2450
[9]   DNAASE FOOTPRINTING - SIMPLE METHOD FOR DETECTION OF PROTEIN-DNA BINDING SPECIFICITY [J].
GALAS, DJ ;
SCHMITZ, A .
NUCLEIC ACIDS RESEARCH, 1978, 5 (09) :3157-3170
[10]   ISOLATION AND CHARACTERIZATION OF THE GENE ENCODING THE RAT ALPHA(1B) ADRENERGIC-RECEPTOR [J].
GAO, B ;
KUNOS, G .
GENE, 1993, 131 (02) :243-247